2022 to 2023 Saw Decrease in Rate of Drug Overdose Deaths in United States
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
THURSDAY, Feb. 20, 2025 -- From 2022 to 2023, there was a decrease in the age-adjusted rate of drug overdose death in the United States, according to a report published in the February Health E-Stats, a publication of the National Center for Health Statistics.
Matthew F. Garnett, M.P.H., and Arialdi M. Miniño, M.P.H., from the National Center for Health Statistics in Hyattsville, Maryland, describe changes in drug overdose mortality by selected drug type and state from 2022 to 2023.
The researchers found that from 2022 to 2023 the age-adjusted rate of drug overdose deaths in the United States decreased 4.0 percent (32.6 to 31.3 deaths per 100,000 standard population). West Virginia and the District of Columbia were the jurisdictions with the highest rates in 2023 (81.9 and 60.7, respectively), while Nebraska and South Dakota were the states with the lowest rates (9.0 and 11.2, respectively). Age-adjusted rates of drug overdose deaths decreased in 20 states, did not change significantly in 25 states, and increased in six states (Alabama, Alaska, California, Nevada, Oregon, and Washington). Nationally, the age-adjusted rate of drug overdose deaths decreased between 2022 and 2023 for deaths involving any opioid and synthetic opioids other than methadone, including fentanyl, and increased for deaths involving psychostimulants with abuse potential and cocaine.
"Changes in rates varied by jurisdiction across drug type," the authors write. "Rates for deaths involving synthetic opioids other than methadone decreased in 17 states and increased in 11 states."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-02-21 12:00
Read more

- Lower Dexamethasone Dose Does Not Impair Survival in Multiple Myeloma
- Stealth BioTherapeutics Announces PDUFA Action Date Extension for Elamipretide to Treat Patients with Barth Syndrome
- Dangerous Blood Clot Sidelines NBA Star Victor Wembanyama for the Season
- Big Breakfasts Help Keep Heart Patients Happy, Study Shows
- Sangamo Therapeutics Announces Updated Phase 1/2 STAAR Study Data for Isaralgagene Civaparvovec in Fabry Disease
- Transcutaneous Electrical Stimulation Aids Gastroesophageal Reflux Disease
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions